Without a hope, page-9

what investors want is a commercial deal. R&D wrapped in bacon will not produce value

COVID-19 has put a hold on BIT-225

BITs existing compounds for COVID-19 are not potent and drugable enough. Back to the drawing board. Not a good look when they started and stated that were well ahead of the pack

BIT225 phase 2b and Phase 3 unfunded

BIT not any closer to a commercial deal than they were 5-10 years ago.

For the sake of my remaining investment, I hope in 2021 we will see BIT being absorbed into other market leaders

Continued R&D will just mean eventual dilution for all holders.

Shares on offer is on the low side, no major instos want to touch this, money is running out and all another reason why they will be heading back to ‘moms and dads’ for ‘money please’ at less inflated stock price

as for MnM, she’s fooled us all, and has set herself up for a luxurious retirement